Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Other Non-Current Liabilities (2022 - 2024)

Spruce Biosciences (SPRB) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $282000.0 as the latest value for Q4 2024.

  • Quarterly Other Non-Current Liabilities rose 19.49% to $282000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $282000.0 through Dec 2024, up 19.49% year-over-year, with the annual reading at $282000.0 for FY2024, 19.49% up from the prior year.
  • Other Non-Current Liabilities for Q4 2024 was $282000.0 at Spruce Biosciences, up from $273000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $282000.0 in Q4 2024, with the low at $95000.0 in Q1 2022.
  • Average Other Non-Current Liabilities over 3 years is $201500.0, with a median of $211000.0 recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities surged 90.53% in 2023, then grew 19.49% in 2024.
  • Over 3 years, Other Non-Current Liabilities stood at $161000.0 in 2022, then soared by 46.58% to $236000.0 in 2023, then rose by 19.49% to $282000.0 in 2024.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $282000.0, $273000.0, and $262000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.